Showing results (21-30 of 81) with videos related to
Sort By:
Pageof 9
BMC Gastroenterology|May 20, 2021
Granulomatous colitis in a patient with metastatic melanoma under immunotherapy: a case report and literature reviewStratigoula Sakellariou, Dionysia N Zouki, Dimitrios C Ziogas, et al.Critical Reviews in Oncology/Hematology|February 9, 2025
HER2-targeted therapies: Unraveling their role in biliary tract cancersCharalampos Theocharopoulos, Ioannis A Ziogas, Benedetto Mungo, et al.Journal for Immunotherapy of Cancer|October 17, 2020
Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapyDimitrios C Ziogas, Frosso Kostantinou, Evangelos Cholongitas, et al.Diseases (Basel, Switzerland)|February 23, 2024
Reaching the Diagnosis of Checkpoint Inhibitor-Induced Diabetes Mellitus in Different Clinical Scenarios: A Real-World Application of Updated Diagnostic CriteriaAnna Angelousi, Dimitrios C Ziogas, Vasiliki Siampanopoulou, et al.Pharmacogenomics|August 12, 2009
MTHFR gene polymorphisms and response to chemotherapy in colorectal cancer: a meta-analysisElias Zintzaras, Dimitrios C Ziogas, Georgios D Kitsios, et al.Current Oncology Reports|February 5, 2026
Toward Microbiome-Informed Melanoma Care: The Gut Microbiota in Melanoma Evolution, Immunotherapy Response and Immune-Related ToxicityDimitrios C Ziogas, Charalampos Theocharopoulos, Anastasios Martinos, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 10, 2025
Bone mineral density changes following immune checkpoint inhibitor therapy: insights from a case series analysisVasiliki Siampanopoulou, Dimitrios C Ziogas, George Lyrarakis, et al.Vaccines|January 22, 2024
New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3Ioannis-Alexios Koumprentziotis, Charalampos Theocharopoulos, Dimitra Foteinou, et al.Therapeutic Advances in Medical Oncology|October 25, 2021
The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literatureAmalia Anastasopoulou, Panagiotis T Diamantopoulos, Chrysanthi Skalioti, et al.Annals of Translational Medicine|June 5, 2018
Treating ALK-positive non-small cell lung cancerDimitrios C Ziogas, Anna Tsiara, Georgios Tsironis, et al.Pageof 9